Rapid identification of occlusive myocardial infarction (OMI) remains challenging in acute coronary syndrome (ACS) without ST-elevation. Artificial intelligence (AI)-assisted electrocardiography (AI-ECG) may enable early recognition before routine workup and allow access to timely reperfusion.
In this two-...
M. Unterhuber, L. Donazzan, F. Vitali et al.· European Heart Journal· 0 citations
AIMS
To investigate the prognostic role of physical performance as a marker of vulnerability in older patients after myocardial infarction and its interaction with a multidomain cardiac rehabilitation intervention.
METHODS AND RESULTS
In this prespecified subanalysis of the PIpELINe trial, physical performance was ev...
A. Raisi, V. Zerbini, E. Tonet et al.· European Journal of Preventi...· 0 citations
Normal-flow, low-gradient aortic stenosis is one of the most deceptive presentations of aortic stenosis. It leaves clinicians uncertain whether they are facing true severe disease or a measurement artefact. This often reflects a discordant grading pattern, in which many patients ultimately prove to have moderate diseas...
L. Rotondo, E. Marchetti, R. Pavasini et al.· Medicina· 0 citations
The noninvasive hemodynamic approach provides an alternative and promising method to stratify the risk of clinical outcome in patients with ATTR-CM, potentially improving management strategies.
Matteo Serenelli, A. Cantone, A. Porcari et al.· JACC: Advances· 0 citations
Left atrial appendage closure has emerged as an established nonpharmacological strategy for stroke prevention in selected patients with atrial fibrillation, particularly those in whom long-term oral anticoagulation is problematic. Its contemporary role, however, is defined by a central tension between procedural precis...
R. Tezze, Cristina Rizza, L. Vocale et al.· Journal of Clinical Medicine· 0 citations
CMR-based radiomics shows considerable potential for improving diagnosis and phenotypic characterization of cardiomyopathies, but methodological standardization, multicenter prospective validation, and demonstration of incremental clinical value are required before routine clinical implementation.
C. Granitto, K. Hoxha, Gianmarco Forasassi et al.· Healthcare· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.